Skip to main content
TipRanks
Go Ultimate75% OFF

Aura Biosciences Inc (AURA) Stock Statistics & Valuation Metrics

330 Followers

Total Valuation

Aura Biosciences Inc has a market cap or net worth of $739.97M. The enterprise value is $416.47M.

Market Cap
$739.97M
Enterprise Value
$416.47M

Share Statistics

Aura Biosciences Inc has 104,074,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
104,074,300
Owned by Insiders
3.71%
Owned by Institutions
32.07%

Financial Efficiency

Aura Biosciences Inc’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -73.10%.

Return on Equity (ROE)
-0.78
Return on Assets (ROA)
-0.63
Return on Invested Capital (ROIC)
-73.10%
Return on Capital Employed (ROCE)
-0.75
Revenue Per Employee
0
Profits Per Employee
-939.74K
Employee Count
113
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Aura Biosciences Inc is -4.26. Aura Biosciences Inc’s PEG ratio is -0.28.

PE Ratio
-4.26
PS Ratio
0.00
PB Ratio
2.75
Price to FCF
-6.75
Price to Operating Cash Flow
-7.23
PEG Ratio
-0.28

Income Statement

In the last 12 months, Aura Biosciences Inc had revenue of 0 and earned -106.19M in profits. Earnings per share was -1.76.

Revenue
0
Gross Profit
0
Operating Income
-112.79M
Pretax Income
-106.08M
Net Income
-106.19M
EBITDA
-104.95M
Earnings Per Share (EPS)
-1.76

Cash Flow

In the last 12 months, operating cash flow was -109.30M and capital expenditures -379,000, giving a free cash flow of -109.68M billion.

Operating Cash Flow
-109.30M
Free Cash Flow
-109.68M
Free Cash Flow per Share
-0.99

Dividends & Yields

Aura Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-14.59%
Earnings Yield
-17.07%

Stock Price Statistics

Beta
1.52
52-Week Price Change
28.57%
50-Day Moving Average
6.54
200-Day Moving Average
6.81
Relative Strength Index (RSI)
57.29
Average Volume (3m)
900.47K

Important Dates

Aura Biosciences Inc upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 09, 2026
Next Earnings Date
Mar 30, 2027
Ex-Dividend Date
―

Financial Position

Aura Biosciences Inc as a current ratio of 8.15, with Debt / Equity ratio of 12.69%

Current Ratio
8.15
Quick Ratio
8.15
Debt to Market Cap
0.04
Net Debt to EBITDA
0.40
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Aura Biosciences Inc has paid 108.00K in taxes.

Income Tax
108.00K
Effective Tax Rate
-0.00

Enterprise Valuation

Aura Biosciences Inc EV to EBITDA ratio is -5.14, with an EV/FCF ratio of -6.62.

EV to Sales
0.00
EV to EBITDA
-5.14
EV to Free Cash Flow
-6.62
EV to Operating Cash Flow
-6.65

Balance Sheet

Aura Biosciences Inc has $297.23M in cash and marketable securities with $16.17M in debt, giving a net cash position of $281.06M billion.

Cash & Marketable Securities
$297.23M
Total Debt
$16.17M
Net Cash
$281.06M
Net Cash Per Share
$2.70
Tangible Book Value Per Share
$2.59

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Aura Biosciences Inc is $18.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$18.00
Price Target Upside
153.16% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
13.33%

Scores

Smart Score
6
AI Score
52